Impact of Prasugrel Re-load on Platelet Aggregation in Patients on Chronic Prasugrel Therapy.
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2013
At a glance
- Drugs Prasugrel (Primary)
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- 17 Jan 2013 Actual end date Sep 2011 added as reported by ClinicalTrials.gov.
- 27 Mar 2012 Results presented at the 61st Annual Scientific Session of the American College of Cardiology.
- 31 Oct 2011 Planned End Date changed from 1 Oct 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.